Abgenix, Inc.
Records under this name other than patents Abgenix, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,585,500 | Fully Human Monoclonal Antibodies to IL-13 Formerly held In force · High confidence | In force | High confidence | |
| US 8,609,090 | Specific Binding Agents to Hepatocyte Growth Factor Formerly held In force · High confidence | In force | High confidence | |
| US 7,592,430 | Antibodies to M-Csf Formerly held Term ended Term ended May 7, 2026 · High confidence | Term ended | Term ended May 7, 2026 | High confidence |
| US 7,968,684 | IL-18 Binding Proteins Formerly held Term ended Term ended Apr 16, 2026 · High confidence | Term ended | Term ended Apr 16, 2026 | High confidence |
| US 7,498,420 | Antibodies to C-Met Formerly held Term ended Term ended Feb 11, 2026 · High confidence | Term ended | Term ended Feb 11, 2026 | High confidence |
| US 7,973,140 | Antibodies Directed to ANGIOPOIETIN-2 and Uses Thereof Formerly held Term ended Term ended Dec 19, 2025 · High confidence | Term ended | Term ended Dec 19, 2025 | High confidence |
| US 8,834,880 | Antibodies Directed to ANGIOPOIETIN-2 and Uses Thereof Formerly held Term ended Term ended Dec 19, 2025 · High confidence | Term ended | Term ended Dec 19, 2025 | High confidence |
| US 10,066,011 | Antibodies Directed to ANGIOPOIETIN-2 and Uses Thereof Formerly held Term ended Term ended Dec 19, 2025 · High confidence | Term ended | Term ended Dec 19, 2025 | High confidence |
| US 7,572,444 | Binding Proteins Specific for Human Matriptase Formerly held Term ended Term ended Dec 16, 2025 · High confidence | Term ended | Term ended Dec 16, 2025 | High confidence |
| US 11,492,411 | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof Formerly held Term ended Term ended Jul 18, 2025 · From the USPTO record | Term ended | Term ended Jul 18, 2025 | From the USPTO record |